Abstract

Kidney transplantation is being performed more frequently for individuals with end stage renal disease (ESRD) due to improved survival and quality of life compared to long-term dialysis. Though rates decrease after transplant, cardiovascular disease (CVD) remains the most common cause of death after kidney transplant. New-onset diabetes after transplant (NODAT), a common complication following kidney transplantation, and pre-transplant diabetes both significantly increase the risk for CVD. Several other risk factors for CVD in kidney transplant recipients have been identified; however, optimal therapy for controlling the risk factors of CVD after kidney transplantation, including NODAT and pretransplant diabetes, is not well defined. In the following review we will discuss the role of traditional and non-traditional risk factors in CVD after kidney transplant and the mechanisms involved therein. We will also examine the current literature regarding treatment of these risk factors for the prevention of CVD. Finally, we will review the current recommendations for pre- and post-transplant cardiovascular evaluation and management.

Original languageEnglish (US)
Pages (from-to)221-234
Number of pages14
JournalCurrent Diabetes Reviews
Volume7
Issue number4
DOIs
StatePublished - Jul 1 2011

Fingerprint

Kidney Transplantation
Cardiovascular Diseases
Transplants
Kidney
Chronic Kidney Failure
Dialysis
Cause of Death
Quality of Life
Survival
Therapeutics

Keywords

  • Cardiovascular disease
  • Diabetes
  • Dyslipidemia
  • Hypertension
  • Kidney transplant
  • Obesity

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

@article{812bee8a2519487891c4f1d6e76ebb39,
title = "Diabetes and Cardiovascular disease following kidney transplantation",
abstract = "Kidney transplantation is being performed more frequently for individuals with end stage renal disease (ESRD) due to improved survival and quality of life compared to long-term dialysis. Though rates decrease after transplant, cardiovascular disease (CVD) remains the most common cause of death after kidney transplant. New-onset diabetes after transplant (NODAT), a common complication following kidney transplantation, and pre-transplant diabetes both significantly increase the risk for CVD. Several other risk factors for CVD in kidney transplant recipients have been identified; however, optimal therapy for controlling the risk factors of CVD after kidney transplantation, including NODAT and pretransplant diabetes, is not well defined. In the following review we will discuss the role of traditional and non-traditional risk factors in CVD after kidney transplant and the mechanisms involved therein. We will also examine the current literature regarding treatment of these risk factors for the prevention of CVD. Finally, we will review the current recommendations for pre- and post-transplant cardiovascular evaluation and management.",
keywords = "Cardiovascular disease, Diabetes, Dyslipidemia, Hypertension, Kidney transplant, Obesity",
author = "Boerner, {Brian P} and Vijay Shivaswamy and Desouza, {Cyrus V} and Larsen, {Jennifer Lynn}",
year = "2011",
month = "7",
day = "1",
doi = "10.2174/157339911796397857",
language = "English (US)",
volume = "7",
pages = "221--234",
journal = "Current Diabetes Reviews",
issn = "1573-3998",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Diabetes and Cardiovascular disease following kidney transplantation

AU - Boerner, Brian P

AU - Shivaswamy, Vijay

AU - Desouza, Cyrus V

AU - Larsen, Jennifer Lynn

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Kidney transplantation is being performed more frequently for individuals with end stage renal disease (ESRD) due to improved survival and quality of life compared to long-term dialysis. Though rates decrease after transplant, cardiovascular disease (CVD) remains the most common cause of death after kidney transplant. New-onset diabetes after transplant (NODAT), a common complication following kidney transplantation, and pre-transplant diabetes both significantly increase the risk for CVD. Several other risk factors for CVD in kidney transplant recipients have been identified; however, optimal therapy for controlling the risk factors of CVD after kidney transplantation, including NODAT and pretransplant diabetes, is not well defined. In the following review we will discuss the role of traditional and non-traditional risk factors in CVD after kidney transplant and the mechanisms involved therein. We will also examine the current literature regarding treatment of these risk factors for the prevention of CVD. Finally, we will review the current recommendations for pre- and post-transplant cardiovascular evaluation and management.

AB - Kidney transplantation is being performed more frequently for individuals with end stage renal disease (ESRD) due to improved survival and quality of life compared to long-term dialysis. Though rates decrease after transplant, cardiovascular disease (CVD) remains the most common cause of death after kidney transplant. New-onset diabetes after transplant (NODAT), a common complication following kidney transplantation, and pre-transplant diabetes both significantly increase the risk for CVD. Several other risk factors for CVD in kidney transplant recipients have been identified; however, optimal therapy for controlling the risk factors of CVD after kidney transplantation, including NODAT and pretransplant diabetes, is not well defined. In the following review we will discuss the role of traditional and non-traditional risk factors in CVD after kidney transplant and the mechanisms involved therein. We will also examine the current literature regarding treatment of these risk factors for the prevention of CVD. Finally, we will review the current recommendations for pre- and post-transplant cardiovascular evaluation and management.

KW - Cardiovascular disease

KW - Diabetes

KW - Dyslipidemia

KW - Hypertension

KW - Kidney transplant

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=79960977536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960977536&partnerID=8YFLogxK

U2 - 10.2174/157339911796397857

DO - 10.2174/157339911796397857

M3 - Review article

C2 - 21644915

AN - SCOPUS:79960977536

VL - 7

SP - 221

EP - 234

JO - Current Diabetes Reviews

JF - Current Diabetes Reviews

SN - 1573-3998

IS - 4

ER -